A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools

被引:1
作者
Pirri, S. [1 ]
Talarico, R. [2 ]
Marinello, D. [2 ]
Turchetti, G. [1 ]
Mosca, M. [2 ]
机构
[1] Scuola Super Sant Anna, Inst Management, Via Santa Cecilia 3, I-56127 Pisa, Italy
[2] Azienda Osped Univ Pisana, Rheumatol Unit, Pisa, Italy
关键词
Literature review; medication adherence; connective tissue diseases; score; instruments; outcomes; co-design; questionnaires; LUPUS-ERYTHEMATOSUS; PREDICTIVE-VALIDITY; PATIENT ADHERENCE; SELF-REPORT; CARE; QUESTIONNAIRE; BARRIERS; RHEUMATOLOGY; PERSISTENCE; THERAPY;
D O I
10.4081/reumatismo.2021.1418
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lack of medication adherence is frequent in chronic connective tissue diseases and is associated with poorer health outcomes, low quality of life and economic loss. This research is based on a systematic literature search and aims to identify the surveys and tools used for the assessment of medication adherence in patients with connective tissue diseases (CTDs) and in particular the tools co-designed with patients. A systematic literature review was performed in PubMed and Embase databases searching for studies concerning the application of surveys or tools designed for medication adherence assessment. A specific analysis was also performed to identify which of these existing tools were developed in co-design with patients affected by CTDs. 1958 references were identified, and 31 studies were finally included. Systemic lupus erythematosus was the most investigated disease, followed by the Behcet's disease. The tools used to assess adherence in CTDs were, in most cases, valid and useful. However, the results showed a certain degree of heterogeneity among the studies and the medication adherence assessment and measurement tools adopted, which were mostly based on selfreported questionnaire. No co-designed tools with patients were found. Low- and non-adherence were explored in some CTDs with valid and useful tools, while other CTDs still need to be assessed. Therefore, more efforts should be made to better understand the specific reasons for the low- and non-adherence in CTDs patients.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 63 条
  • [1] Ali AY, 2019, CURR RHEUMATOL REV, V15
  • [2] Medication adherence, depression and disease activity among patients with systemic lupus erythematosus
    Alsowaida, N.
    Alrasheed, M.
    Mayet, A.
    Alsuwaida, A.
    Omair, M. A.
    [J]. LUPUS, 2018, 27 (02) : 327 - 332
  • [3] Amalia R, 2019, INDIAN J PUBLIC HLTH, V10, P672, DOI DOI 10.5958/0976-5506.2019.00580.1
  • [4] Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review
    Anghel, Laura-Alexandra
    Farcas, Andreea Maria
    Oprean, Radu Nicolae
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1151 - 1166
  • [5] The role of patient attachment and working alliance on patient adherence, satisfaction, and health-related quality of life in lupus treatment
    Bennett, Jennifer K.
    Fuertes, Jairo N.
    Keitel, Merle
    Phillips, Robert
    [J]. PATIENT EDUCATION AND COUNSELING, 2011, 85 (01) : 53 - 59
  • [6] Treatment adherence in systemic sclerosis: A cross-sectional study
    Brijs, Jan
    Arat, Seher
    Westhovens, Rene
    Lenaerts, Jan Leo
    De Langhe, Ellen
    [J]. MUSCULOSKELETAL CARE, 2019, 17 (01) : 44 - 53
  • [7] Medication Adherence: WHO Cares?
    Brown, Marie T.
    Bussell, Jennifer K.
    [J]. MAYO CLINIC PROCEEDINGS, 2011, 86 (04) : 304 - 314
  • [8] Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica
    Chambers, S.
    Raine, R.
    Rahman, A.
    Hagley, K.
    De Ceulaer, K.
    Isenberg, D.
    [J]. LUPUS, 2008, 17 (08) : 761 - 769
  • [9] Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications A qualitative study in a UK cohort
    Chambers, S. A.
    Raine, R.
    Rahman, A.
    Isenberg, D.
    [J]. RHEUMATOLOGY, 2009, 48 (03) : 266 - 271
  • [10] Statistical considerations for rare diseases drug development
    Chow, Shein-Chung
    Chang, Yu-Wei
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (05) : 874 - 886